Pediatric Stroke: What Do We Know and What Do We Need to Know?

ABSTRACT

Stroke is a heterogeneous disorder and an important cause of mortality and chronic morbidity in children. Estimates of international incidence rates for childhood stroke have varied widely. Arterial ischemic stroke is reported to be more common than hemorrhagic stroke in children. The clinical presentation of stroke in children differs according to the child's age and stroke type and location. Several risk factors for ischemic and hemorrhagic stroke in children have been reported and include cardiac disorders, blood disorders, vasculopathies, viral infections, and arteriovenous malformations. Current treatment recommendations for stroke in children are based on small nonrandomized trials, adult stroke studies, case series, or consensus or individual expert opinion. Over half of children with stroke will develop lifelong cognitive or motor disability, and up to a third will have a recurrent stroke. International studies have provided important information on stroke in children, but major gaps in our knowledge of the disorder still exist. Currently, there is a need for prospective cohort studies in diverse populations, which utilize a consensus pediatric stroke classification system and a standard evaluation of risk factors and outcome, so that treatment and prevention strategies can be developed.

KEYWORDS

Cerebrovascular diseases - child

REFERENCES

• 1 Earley C J, Kittner S J, Feeser B R et al.. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study.  Neurology. 1998;  51 169-176
• 2 Giroud M, Lemesle M, Gouyon J B, Nivelon J L, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993.  J Clin Epidemiol. 1995;  48 1343-1348
• 3 Schoenberg B S, Mellinger J F, Schoenberg D G. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival.  Neurology. 1978;  28 763-768
• 4 Paediatric Stroke Working Group .Stroke in Childhood: Clinical Guidelines for Diagnosis, Management and Rehabilitation. London; Royal College of Physicians 2004
• 5 Monagle P, Chan A, Massicotte P, Chalmers E, Michelson A D. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 645S-687S
• 6 Lynch J K. The hospitalization of childhood stroke in the United States, 1979 2000 [abstract].  Stroke. 2003;  34 287
• 7 Fullerton H J, Wu Y W, Zhao S, Johnston S C. Risk of stroke in children: ethnic and gender disparities.  Neurology. 2003;  61 189-194
• 8 Ganesan V, Prengler M, McShane M A, Wade A M, Kirkham F J. Investigation of risk factors in children with arterial ischemic stroke.  Ann Neurol. 2003;  53 167-173
• 9 Gabis L V, Yangala R, Lenn N J. Time lag to diagnosis of stroke in children.  Pediatrics. 2002;  110 924-928
• 10 Wraige E, Hajat C, Jan W, Pohl K R, Wolfe C D, Ganesan V. Ischaemic stroke subtypes in children and adults.  Dev Med Child Neurol. 2003;  45 229-232
• 11 Strater R, Becker S, von Eckardstein A et al.. Prospective assessment of risk factors for recurrent stroke during childhood: a 5-year follow-up study.  Lancet. 2002;  360 1540-1545
• 12 Kirkham F J, Prengler M, Hewes D K, Ganesan V. Risk factors for arterial ischemic stroke in children.  J Child Neurol. 2000;  15 299-307
• 13 Kumar K. Neurological complications of congenital heart disease.  Indian J Pediatr. 2000;  67 S15-S19
• 14 Lanska M J, Lanska D J, Horwitz S J, Aram D M. Presentation, clinical course, and outcome of childhood stroke.  Pediatr Neurol. 1991;  7 333-341
• 15 DeVeber G. and the Canadian Ischemic Stroke Study Group . Canadian Pediatric Stroke Registry: analysis of children with arterial ischemic stroke [abstract].  Ann Neurol. 2000;  48 526
• 16 Strauss A, Toth B, Schwab B et al.. Prenatal diagnosis of congenital heart disease and neonatal outcome: a six years experience.  Eur J Med Res. 2001;  6 66-70
• 17 Mahle W T, Tavani F, Zimmerman R A et al.. An MRI study of neurological injury before and after congenital heart surgery.  Circulation. 2002;  106 I109-I114
• 18 Kirkham F J. Recognition and prevention of neurological complications in pediatric cardiac surgery.  Pediatr Cardiol. 1998;  19 331-345
• 19 Chun D S, Schamberger M S, Flaspohler T et al.. Incidence, outcome, and risk factors for stroke after the Fontan procedure.  Am J Cardiol. 2004;  93 117-119
• 20 Chan A K, deVeber G. Prothrombotic disorders and ischemic stroke in children.  Semin Pediatr Neurol. 2000;  7 301-308
• 21 Scothorn D J, Price C, Schwartz D et al.. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.  J Pediatr. 2002;  140 348-354
• 22 Pegelow C H, Macklin E A, Moser F G et al.. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.  Blood. 2002;  99 3014-3018
• 23 Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease.  Am J Med. 1978;  65 461-471
• 24 Buchanan G R, DeBaun M R, Quinn C T, Steinberg M H. Sickle cell disease.  Hematology (Am Soc Hematol Educ Program). 2004;  35-47
• 25 Hoppe C, Klitz W, Cheng S et al.. Gene interactions and stroke risk in children with sickle cell anemia.  Blood. 2004;  103 2391-2396
• 26 Adams R J. Stroke prevention and treatment in sickle cell disease.  Arch Neurol. 2001;  58 565-568
• 27 Steen R G, Emudianughe T, Hankins G M et al.. Brain imaging findings in pediatric patients with sickle cell disease.  Radiology. 2003;  228 216-225
• 28 Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct.  J Child Neurol. 1999;  14 749-751
• 29 Kenet G, Sadetzki S, Murad H et al.. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.  Stroke. 2000;  31 1283-1288
• 30 Nowak-Gottl U, Strater R, Heinecke A et al.. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.  Blood. 1999;  94 3678-3682
• 31 Hagstrom J N, Walter J, Bluebond-Langner R, Amatniek J C, Manno C S, High K A. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease.  J Pediatr. 1998;  133 777-781
• 32 Bonduel M, Sciuccati G, Hepner M et al.. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism.  Am J Hematol. 2003;  73 81-86
• 33 McColl M D, Chalmers E A, Thomas A et al.. Factor V Leiden, prothrombin 20210G→A and the MTHFR C677T mutations in childhood stroke.  Thromb Haemost. 1999;  81 690-694
• 34 Zenz W, Bodo Z, Plotho J et al.. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke.  Thromb Haemost. 1998;  80 763-766
• 35 Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients.  J Child Neurol. 2000;  15 290-294
• 36 Sebire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood.  Curr Opin Pediatr. 2004;  16 617-622
• 37 Fullerton H J, Johnston S C, Smith W S. Arterial dissection and stroke in children.  Neurology. 2001;  57 1155-1160
• 38 McKusick V A. Online Mendelian Inheritance in Man Web site. http://Available at: www3.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM Accessed November 4, 2005
• 39 Fung L W, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature.  Childs Nerv Syst. 2005;  21 358-364
• 40 Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.  Am J Hum Genet. 1999;  64 533-537
• 41 Inoue T K, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6.  J Child Neurol. 2000;  15 179-182
• 42 Sakurai K, Horiuchi Y, Ikeda H et al.. A novel susceptibility locus for moyamoya disease on chromosome 8q23.  J Hum Genet. 2004;  49 278-281
• 43 Yamauchi T, Tada M, Houkin K et al.. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.  Stroke. 2000;  31 930-935
• 44 Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmiedek P. Moyamoya-like vasculopathy (moyamoya syndrome) in children.  Childs Nerv Syst. 2004;  20 382-391
• 45 Czartoski T, Hallam D, Lacy J M, Chun M R, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome.  J Neurol Neurosurg Psychiatry. 2005;  76 256-259
• 46 Lindsberg P J, Grau A J. Inflammation and infections as risk factors for ischemic stroke.  Stroke. 2003;  34 2518-2532
• 47 Snyder R D, Stovring J, Cushing A H, Davis L E, Hardy T L. Cerebral infarction in childhood bacterial meningitis.  J Neurol Neurosurg Psychiatry. 1981;  44 581-585
• 48 Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study.  Ann Neurol. 1999;  45 679-680
• 49 Narayan P, Samuels O B, Barrow D L. Stroke and pediatric human immunodeficiency virus infection: case report and review of the literature.  Pediatr Neurosurg. 2002;  37 158-163
• 50 Guidi B, Bergonzini P, Crisi G, Frigieri G, Portolani M. Case of stroke in a 7-year-old male after parvovirus B19 infection.  Pediatr Neurol. 2003;  28 69-71
• 51 Bell M L, Buchhalter J R. Influenza A-associated stroke in a 4-year-old male.  Pediatr Neurol. 2004;  31 56-58
• 52 Askalan R, Laughlin S, Mayank S et al.. Chickenpox and stroke in childhood: a study of frequency and causation.  Stroke. 2001;  32 1257-1262
• 53 Ichiyama T, Houdou S, Kisa T, Ohno K, Takeshita K. Varicella with delayed hemiplegia.  Pediatr Neurol. 1990;  6 279-281
• 54 Wirrell E, Hill M D, Jadavji T, Kirton A, Barlow K. Stroke after varicella vaccination.  J Pediatr. 2004;  145 845-847
• 55 Hutchison J S, Ichord R, Guerguerian A M, deVeber G. Cerebrovascular disorders.  Semin Pediatr Neurol. 2004;  11 139-146
• 56 Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients.  Stroke. 2000;  31 410-414
• 57 Inamasu J, Ichikizaki K, Matsumoto S et al.. Mild hypothermia for hemispheric cerebral infarction after evacuation of an acute subdural hematoma in an infant.  Childs Nerv Syst. 2002;  18 175-178
• 58 Adelson P D, Bratton S L, Carney N A et al.. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 8: cerebral perfusion pressure.  Pediatr Crit Care Med. 2003;  4 S31-S33
• 59 Capes S E, Hunt D, Malmberg K, Pathak P, Gerstein H C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.  Stroke. 2001;  32 2426-2432
• 60 Wirrell E C, Armstrong E A, Osman L D, Yager J Y. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage.  Pediatr Res. 2001;  50 445-454
• 61 Thirumalai S S, Shubin R A. Successful treatment for stroke in a child using recombinant tissue plasminogen activator.  J Child Neurol. 2000;  15 558
• 62 Noser E A, Felberg R A, Alexandrov A V. Thrombolytic therapy in an adolescent ischemic stroke.  J Child Neurol. 2001;  16 286-288
• 63 Golomb M R, Rafay M, Armstrong D et al.. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl.  J Child Neurol. 2003;  18 420-423
• 64 Younkin D P. Diagnosis and treatment of ischemic pediatric stroke.  Curr Neurol Neurosci Rep. 2002;  2 18-24
• 65 Lee M C, Frank J I, Kahana M, Tonsgard J H, Frim D M. Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke: case report and review.  Pediatr Neurosurg. 2003;  38 181-185
• 66 Adams R J, McKie V C, Hsu L et al.. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.  N Engl J Med. 1998;  339 5-11
• 67 NHLBI Communications Office .NHLBI stops study testing how long children with sickle cell anemia should have blood transfusions to prevent stroke. NIH news Web site. http://Available at: www.nih.gov/news/pr/dec2004/nhlbi-05.htm Accessed December 5, 2004
• 68 Clancy R R, McGaurn S A, Goin J E et al.. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest.  Pediatrics. 2001;  108 61-70
• 69 Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children.  Neurosurg Clin N Am. 2001;  12 575-584 , ix
• 70 Miyamoto S. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset. The Japan Adult Moyamoya Trial Group.  Neurol Med Chir (Tokyo). 2004;  44 218-219
• 71 Bonduel M, Hepner M, Sciuccati G, Torres A F, Tenembaum S. Prothrombotic disorders in children with moyamoya syndrome.  Stroke. 2001;  32 1786-1792
• 72 Andrew M, Monagle P T, Brooker L. Thromboembolic Complications During Infancy and Childhood. 1st ed. Hamilton, Ontario; B.C. Decker, Inc. 2000
• 73 Wang W C, Kovnar E H, Tonkin I L et al.. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.  J Pediatr. 1991;  118 377-382
• 74 Sumoza A, de Bisotti R, Sumoza D, Fairbanks V. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).  Am J Hematol. 2002;  71 161-165
• 75 National Institutes of Health .Phase I/II study of nonmyeloablative allogeneic bone marrow transplantation in patients with high risk hemoglobinopathy. Available at: http://www.clinicaltrials.gov Accessed NOvember 4, 2005
• 76 Ganesan V, Ng V, Chong W K, Kirkham F J, Connelly A. Lesion volume, lesion location, and outcome after top cerebral artery territory stroke.  Arch Dis Child. 1999;  81 295-300
• 77 deVeber G, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis.  J Child Neurol. 2000;  15 316-324
• 78 Hartel C, Schilling S, Sperner J, Thyen U. The clinical outcomes of neonatal and childhood stroke: review of the literature and implications for future research.  Eur J Neurol. 2004;  11 431-438
• 79 Lansing A E, Max J E, Delis D C et al.. Verbal learning and memory after childhood stroke.  J Int Neuropsychol Soc. 2004;  10 742-752
• 80 Max J E. Effect of side of lesion on neuropsychological performance in childhood stroke.  J Int Neuropsychol Soc. 2004;  10 698-708
• 81 Ballantyne A O, Trauner D A. Facial recognition in children after perinatal stroke.  Neuropsychiatry Neuropsychol Behav Neurol. 1999;  12 82-87
• 82 Max J E, Mathews K, Lansing A E et al.. Psychiatric disorders after childhood stroke.  J Am Acad Child Adolesc Psychiatry. 2002;  41 555-562
• 83 Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham F J. Outcome after ischaemic stroke in childhood.  Dev Med Child Neurol. 2000;  42 455-461
• 84 deVeber G, Monagle P, Chan A et al.. Prothrombotic disorders in infants and children with cerebral thromboembolism.  Arch Neurol. 1998;  55 1539-1543
• 85 Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome.  Neurology. 2000;  54 371-378
• 86 Lanthier S, Kirkham F J, Mitchell L G et al.. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children.  Neurology. 2004;  62 194-200
• 87 Strater R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Gottl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study.  Stroke. 2001;  32 2554-2558
• 88 Wang L H, Young C, Lin H C, Wang P J, Lee W T, Shen Y Z. Strokes in children: a medical center-based study.  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998;  39 242-246
• 89 Arias E, Anderson R N, Kung H C, Murphy S L, Kochanek K D. Deaths: final data for 2001.  Natl Vital Stat Rep. 2003;  52 1-115
• 90 Fullerton H J, Chetkovich D M, Wu Y W, Smith W S, Johnston S C. Deaths from stroke in US children, 1979 to 1998.  Neurology. 2002;  59 34-39
• 91 Broderick J, Talbot G T, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage.  J Child Neurol. 1993;  8 250-255
• 92 Meyer-Heim A D, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome.  Brain Dev. 2003;  25 416-421
• 93 Al Jarallah A, Al Rifai M T, Riela A R, Roach E S. Nontraumatic brain hemorrhage in children: etiology and presentation.  J Child Neurol. 2000;  15 284-289
• 94 May Llanas M E, Alcover B E, Cambra Lasaosa F J, Campistol P J, Palomeque R A. [Non-traumatic cerebral hemorrhage in childhood: etiology, clinical manifestations and management].  An Esp Pediatr. 1999;  51 257-261
• 95 Eeg-Olofsson O, Ringheim Y. Stroke in children: clinical characteristics and prognosis.  Acta Paediatr Scand. 1983;  72 391-395
• 96 Livingston J H, Brown J K. Intracerebral haemorrhage after the neonatal period.  Arch Dis Child. 1986;  61 538-544
• 97 Visudhiphan P, Chiemchanya S, Wattanasirichaigoon D. Strokes in Thai children: etiology and outcome.  Southeast Asian J Trop Med Public Health. 1996;  27 801-805
• 98 Veira C, Castro-Vilanova D, Ferreiro A et al.. [Spontaneous intracranial hemorrhages in childhood].  Rev Neurol. 1997;  25 1381-1382
• 99 Marzo-Sola M E, Carod-Artal J, Garaizar C, Prats-Vinas J M. [Intraparenchymal hematomas: specific features in children].  Rev Neurol. 1998;  26 561-563
• 100 Blom I, De Schryver E L, Kappelle L J, Rinkel G J, Jennekens-Schinkel A, Peters A C. Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study.  Dev Med Child Neurol. 2003;  45 233-239
• 101 Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects.  Pediatrics. 2004;  114 e206-e212
• 102 Di Rocco C, Tamburrini G, Rollo M. Cerebral arteriovenous malformations in children.  Acta Neurochir (Wien). 2000;  142 145-156
• 103 Fults D, Kelly D LJ. Natural history of arteriovenous malformations of the brain: a clinical study.  Neurosurgery. 1984;  15 658-662
• 104 Punt J. Surgical management of paediatric stroke.  Pediatr Radiol. 2004;  34 16-23
• 105 Kaplan R N, Bussel J B. Differential diagnosis and management of thrombocytopenia in childhood.  Pediatr Clin North Am. 2004;  51 1109-1140 , xi
• 106 Butros L J, Bussel J B. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis.  J Pediatr Hematol Oncol. 2003;  25 660-664
• 107 Journeycake J M, Buchanan G R. Coagulation disorders.  Pediatr Rev. 2003;  24 83-91
• 108 Nelson Jr M D, Maeder M A, Usner D et al.. Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study.  Haemophilia. 1999;  5 306-312
• 109 Klinge J, Auberger K, Auerswald G, Brackmann H H, Mauz-Korholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs: a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH).  Eur J Pediatr. 1999;  158(suppl 3) S162-S165
• 110 Revel-Vilk S, Golomb M R, Achonu C et al.. Effect of intracranial bleeds on the health and quality of life of boys with hemophilia.  J Pediatr. 2004;  144 490-495
• 111 Laurent J P, Bruce D A, Schut L. Hemorrhagic brain tumors in pediatric patients.  Childs Brain. 1981;  8 263-270
• 112 Roach E S, Riela A R. Pediatric Cerebrovascular Disorders. 2nd ed. Armonk, NY; Futura Publishing Company 1995
• 113 Broderick J P, Adams Jr H P, Barsan W et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Stroke. 1999;  30 905-915
• 114 Smith E R, Butler W E, Ogilvy C S. Surgical approaches to vascular anomalies of the child's brain.  Curr Opin Neurol. 2002;  15 165-171
• 115 Fullerton H J, Elkins J S, Johnston S C. Pediatric Stroke Belt: geographic variation in stroke mortality in US children.  Stroke. 2004;  35 1570-1573
• 116 Sudlow C L, Warlow C P. Comparing stroke incidence worldwide: what makes studies comparable?.  Stroke. 1996;  27 550-558
• 117 Hogan A M, Kirkham F J, Isaacs E B. Intelligence after stroke in childhood: review of the literature and suggestions for future research.  J Child Neurol. 2000;  15 325-332
• 118 Sungarian A, Duncan III J A. Vertebrobasilar thrombosis in children: report of two cases and recommendations for treatment.  Pediatr Neurosurg. 2003;  38 16-20
• 119 Andrew M, DeVeber G. Pediatric Thromboembolism and Stroke Protocols. 2nd ed. Hamilton, Ontario; B.C. Decker Inc. 1999
• 120 Gulbis B, Haberman D, Dufour D et al.. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.  Blood. 2005;  105 2685-2690
• 121 Scott R M, Smith J L, Robertson R L, Madsen J R, Soriano S G, Rockoff M A. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.  J Neurosurg. 2004;  100 142-149
• 122 Khan N, Schuknecht B, Boltshauser E et al.. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.  Acta Neurochir (Wien). 2003;  145 1061-1071
• 123 Fryer R H, Anderson R C, Chiriboga C A, Feldstein N A. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.  Pediatr Neurol. 2003;  29 124-130
• 124 Kim C Y, Wang K C, Kim S K, Chung Y N, Kim H S, Cho B K. Encephaloduroarteriosynangiosis with bifrontal encephalogaleo (periosteal) synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes.  Childs Nerv Syst. 2003;  19 316-324
• 125 Cardo E, Monros E, Colome C et al.. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status.  J Child Neurol. 2000;  15 295-298
• 126 Ware R E, Zimmerman S A, Sylvestre P B et al.. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.  J Pediatr. 2004;  145 346-352
• 127 Walters M C, Storb R, Patience M et al.. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.  Blood. 2000;  95 1918-1924
• 128 Isler W. Cerebrovascular diseases in the first three years of life.  Brain Dev. 1980;  2 95-105
• 129 Abram H S, Knepper L E, Warty V S, Painter M J. Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke.  J Child Neurol. 1996;  11 276-282
• 130 Beran-Koehn M A, Brown R D, Mellinger J F, Christianson T J, O'Fallon W M. Cerebrovascular disease in children: Incidence, etiology and outcome.  Neurology. 1999;  52(suppl 2) A43
• 131 De Schryver E L, Kappelle L J, Jennekens-Schinkel A, Boudewyn Peters A C. Prognosis of ischemic stroke in childhood: a long-term follow-up study.  Dev Med Child Neurol. 2000;  42 313-318
• 132 Delsing B J, Catsman-Berrevoets C E, Appel I M. Early prognostic indicators of outcome in ischemic childhood stroke.  Pediatr Neurol. 2001;  24 283-289
• 133 Bjornstad A, Skjeldal O H. [Ischemic stroke in children: a diagnostic challenge].  Tidsskr Nor Laegeforen. 2001;  121 1826-1828
• 134 Brankovic-Sreckovic V, Milic-Rasic V, Jovic N, Milic N, Todorovic S. The recurrence risk of ischemic stroke in childhood.  Med Princ Pract. 2004;  13 153-158
• 135 Barnes C, Newall F, Furmedge J, Mackay M, Monagle P. Arterial ischaemic stroke in children.  J Paediatr Child Health. 2004;  40 384-387
• 136 Lin C L, Loh J K, Kwan A L, Howng S L. Spontaneous intracerebral hemorrhage in children.  Kaohsiung J Med Sci. 1999;  15 146-151